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1. Introduction
Superficial femoral artery, traditionally grouped together with the popliteal artery, as femo-
ral popliteal segment, is the most common localization of peripheral artery disease (70%). 
Atherosclerotic disease of superficial femoral artery is deemed high risk to present with dif-
fuse distribution, frequent calcification, large plaque burden, and high progression rate to 
total occlusion [1]. Additionally, femoral popliteal segment is exposed to significant flexion, 
bending, and compression forces. Hence, unique anatomical features, along with nonfavor-
able atherosclerotic plaques characterize in this region, contributes to a significant challenge, 
when treating this disease. Apart from the variation in the anatomy and the presentation of 
the pathology in superficial femoral artery area, there are many unique features in the presen-
tation and diagnosis as well. These in concert with the downstream areas of supply at risk, can 
present with pain on exertion, pain at rest, or/and with nonhealing ulcers extending anywhere 
from thigh to feet area. It is crucial to understand that while these issues could arise from focal 
stenosis at the presentation level, consideration should always be given to an inflow lesion.
2. Anatomy
Superficial femoral artery arises, at the level of the femoral head, as the continuation of the 
common femoral artery, medially and anteriorly to profunda femoral artery. After the origin, 
superficial femoral artery enters the femoral triangle, coursing toward the abductor canal. 
Subsequently, it leaves the abductor canal through abductor hiatus to enter the popliteal fossa. 
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At this level, the artery name is changing to the popliteal artery, which usually bifurcates into 
the anterior tibial artery and tibioperoneal trunk. One of the unique features of superficial 
femoral artery is lack of the major branches. The only named branch is the descending genicu-
lar branch, contributing to collateral flow of the knee when there is a stenosis in the area. 
Additionally, when discussing the superficial femoral artery disease, profunda femoral branch 
deserves a special attention, as the potential source of significant collateral flow, which should 
be evaluated before decision-making about the intervention on superficial femoral artery [2].
Anatomy is especially important when evaluating the superficial femoral arterial stenosis 
in patients with concerning clinical presentation on abdominal aiortogram with run-off. In 
cardiac catheterization laboratory, we place a pigtail in the abdominal aorta above the level 
of iliac bifurcation. There is an option of performing stepped digital subtraction views with 
100 ml contrast at the rate of 10–15 ml/sec. The alternative option is to cross over the iliac artery 
of the affected lower extremity and then use 50 ml contrast at the flow rate of 10 ml/sec for 
the imaging. Adequate images can be obtained if patient does not move the lower extremities.
3. Pathophysiology of superficial femoral arterial (SFA) disease
While the pathology can range from atherosclerosis to thrombosis, the majority is attributed to 
atherosclerosis in the lower extremities. The detailed pathophysiology has been described in the 
chapter of aortoiliac disease. As outlined above, atherosclerotic disease of superficial femoral 
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artery is characterized by diffuse distribution, significant plaque burden, frequent calcification, 
and the high risk of progression to total occlusion, which is likely dictated by distinguishable 
anatomical features, including significant length of the segment, measuring about 50 cm in an 
average adult patient. The management is dictated by the extent, location, and intensity of the 
stenosis and calcification. It can range from medical therapy alone to aggressive interventional 
approaches. The interventional approaches can range from percutaneous interventions to sur-
gical interventions, again based upon the extent of pathology and patient clinical risk factors.
4. Clinical symptoms and diagnosis
Clinically, intermittent claudication is the classic symptom of peripheral arterial disease 
(PAD). Usually, patients with SFA disease endorse pain in the upper two-thirds of the calf. 
Nevertheless, approximately only 10% of patients report these symptoms. About half of them 
complain about atypical leg pain and about 40% remain asymptomatic. Acute limb ischemia 
is an uncommon presentation (1–2%) [3]. However, it can be limb threatening.
Usually, the diagnosis of PAD is made clinically based upon symptoms and signs. Physical 
examination typically reveals diminished peripheral pulses and skin changes over the poorly 
supplied area. Elevation pallor and dependent rubor are signs of advanced PAD. Physical 
examination may be helpful in localizing the segment of obstruction. Intact femoral pulses, 
diminishing peripherally and vascular bruit over the SFA are suggestive about this vessel 
involvement. Ankle brachial index (ABI) is a useful confirmatory test for PAD (ABI ratio < 
0.9). Pursuing topography is justified in case of potential intervention. The approach to the 
patient with suspected PAD and information about testing modalities were outlined in detail 
in the chapter dedicated to aortoiliac disease.
5. Classification
Clinical symptoms are the fundaments of Fontaine classification. This is a widely used system, 
encompassing four stages of PAD, ranging from asymptomatic disease to apparent necrosis of 
the limb (Table 1). Similarly, Rutherford classification included patient’s symptoms, but was 
enriched by objective data, not requiring invasive measures (Table 2) [4].
Anatomically, SFA has been grouped together with neighboring arterial vessels as the femoral 
popliteal segment. This facilitates the management even more significantly. Further anatomi-
cal details about the lesion, including the disease pattern and the number of changes, were 
incorporated into Trans-Atlantic Inter-Society Consensus (TASC II). This classification distin-
guishes type A, B, C, and D type. Accordingly, lesions vary from relatively short stenosis or 
occlusion to more diffuse changes. This dictates the management plan from medical therapy 
to revascularization. Importantly, TASC II additionally provides guidelines regarding the 
treatment strategy, based on intervention success rate. Detailed classification, in relation to 
femoral popliteal segment was presented in Table 3 [5].
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Grade Category Presentation Objective measures
0 0 No symptoms Treadmill test and reactive hyperemia test 
within normal limits
1 Mild intermittent claudication Can complete treadmill test. Ankle pressure 
post exertion >50 mmHg, but ≥20 mmHg 
lower than at rest
I 2 Moderate intermittent claudication Between mild and severe claudication
3 Severe claudication Unable to complete treadmill test. Ankle 
pressure post exertion <50 mmHg
II 4 Symptoms at rest Ankle pressure <40 mmHg at rest. Toe 
pressure <30 mmHg
III 5 Minor tissue loss, focal gangrene,  
and ischemic ulceration
Ankle pressure <60 mmHg at rest. Toe 
pressure <40 mmHg
6 Tissue loss spreading above metatarsal 
level, extremity cannot be preserved 
any longer
Same as above
Table 2. PAD classification system by Rutherford.
Stage I – No symptoms
Stage II – Mild claudication
Stage IIa – Intermittent claudication >200 m walking distance
Stage IIb – Intermittent claudication <200 m walking distance
Stage III – Pain at rest
Stage IV – Ulceration/gangrene due to ischemia
Table 1. PAD classification system by Fontaine.
Type A lesion
Solitary stenosis <10 cm in length
Solitary occlusion <5 cm in length
Type B lesion
Solitary, severally calcified stenosis <5 cm in length
Many lesions, each <5 cm in length
Solitary lesion <15 cm in length
Type C lesion
Multiple lesions totaling >15 cm in length
Recurring lesions after treatment failure
Type D lesion
Chronic total occlusion of SFA > 20 cm in length.
Table 3. SFA lesions – TASC II classification system.
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6. Treatment
All patients with PAD should be treated initially the same way with pharmacotherapy, 
including antiplatelet medications and high-intensity statin, risk factors control, and exercise 
program, irrespectively of the localization of the lesion. Medical therapy is paramount in the 
management and should be instituted. Revascularization is a modality reserved for selected 
cases, including no adequate symptoms control despite appropriate conservative treatment 
and acute limb ischemia [6]. Detailed information regarding conservative management based 
on the most recent trials was outlined in the chapter of aortoiliac disease.
7. Revascularization
Revascularization, as mentioned above, is a treatment option only for selected patients with 
SFA disease. Traditionally, femoral popliteal segment used to be treated with vein bypass 
surgery. Nevertheless, over the last decades, a rapid evolution of endovascular techniques 
revolutionized the treatment of PAD. Admittedly, endovascular treatment of SFA disease 
appears to be specifically complex due to unique biophysical forces over his body area along 
with often diffuse and calcified atherosclerotic lesions, leading to suboptimal endovascular 
treatment results and stent restenosis as the significant problem affecting long-term outcome. 
However, the tendency is pointing toward improving morbidity and mortality index after 
endovascular treatment [7]. Currently, according to TASC II Update (2015), endovascular 
approach is the preferred method of treating femoropopliteal lesion up to 10 cm in length [5]. 
Different modalities of invasive treatment have been presented in a separate chapter.
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